Finance

Lists
Why is 4DX down 2,74%?
Dive Deeper
4DX:ASX
4DMedical Ltd
2,13ย A$
-2,74%
(-0,060) 1D
17 ีถีธีต, 16:10:07 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for 4DX...
Open
2,14ย A$
High
2,19ย A$
Low
2,02ย A$
Mkt. cap
1,28ย ีดีฌึ€ีค
Avg. vol.
5,12ย ีดีฌีถ
Volume
6,65ย ีดีฌีถ
52-wk high
7,55ย A$
52-wk low
1,40ย A$
EPS
-0,38ย A$
Shares outstanding
602,34ย ีดีฌีถ
No. of employees
181
Open
2,14ย A$
High
2,19ย A$
Low
2,02ย A$
Mkt. cap
1,28ย ีดีฌึ€ีค
Avg. vol.
5,12ย ีดีฌีถ
Volume
6,65ย ีดีฌีถ
52-wk high
7,55ย A$
52-wk low
1,40ย A$
EPS
-0,38ย A$
Shares outstanding
602,34ย ีดีฌีถ
No. of employees
181
News stories
From web sources and news partners
Barron's
Barron's
·
9 ึ€ีธีบีฅ ีกีผีกีป
Bear Market Watch: What the Charts Say About the S&P 500
Benzinga
Benzinga
·
25 ึ€ีธีบีฅ ีกีผีกีป
Walmart Stock Posts Best 2-Month Run Vs. S&P 500 Since 1975 - Walmart (NASDAQ:WMT)
TradingView
TradingView
·
2 ีชีกีด ีกีผีกีป
Wells Fargo sets 2027 S&P 500 year-end target at 8,200
Traders Union
Traders Union
·
51 ึ€ีธีบีฅ ีกีผีกีป
S&P 500 trades near AVWAP and key retracement lines, Chris Ciovacco notes
Profile
4DMedical is a medical technology company, based in Australia and the United States. 4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breathโ€”providing clinicians with quantitative lung ventilation data in a report. 4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
About 4DMedical Ltd
CEOAndreas Fouras
Employees181
Founded2013
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ีฉ. ีฝีฅีบ
2025 ีฉ. ีคีฅีฏ
2026 ีฉ. ีดึ€ีฟ
2026 ีฉ. ีฐีถีฝ
Revenue
1,43ย ีดีฌีถ
1,43ย ีดีฌีถ
2,10ย ีดีฌีถ
2,10ย ีดีฌีถ
Cost of goods sold
98,18ย ีฐีฆึ€
98,18ย ีฐีฆึ€
121,86ย ีฐีฆึ€
121,86ย ีฐีฆึ€
Cost of revenue
98,18ย ีฐีฆึ€
98,18ย ีฐีฆึ€
121,86ย ีฐีฆึ€
121,86ย ีฐีฆึ€
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,22ย ีดีฌีถ
9,22ย ีดีฌีถ
10,40ย ีดีฌีถ
10,40ย ีดีฌีถ
Operating expense
14,59ย ีดีฌีถ
14,59ย ีดีฌีถ
17,45ย ีดีฌีถ
17,45ย ีดีฌีถ
Total operating expenses
14,68ย ีดีฌีถ
14,68ย ีดีฌีถ
17,58ย ีดีฌีถ
17,58ย ีดีฌีถ
Operating income
-13,26ย ีดีฌีถ
-13,26ย ีดีฌีถ
-15,47ย ีดีฌีถ
-15,47ย ีดีฌีถ
Other non operating income
5,12ย ีดีฌีถ
5,12ย ีดีฌีถ
2,42ย ีดีฌีถ
2,42ย ีดีฌีถ
EBT including unusual items
-77,54ย ีดีฌีถ
-77,54ย ีดีฌีถ
-25,25ย ีดีฌีถ
-25,25ย ีดีฌีถ
EBT excluding unusual items
-77,54ย ีดีฌีถ
-77,54ย ีดีฌีถ
-25,22ย ีดีฌีถ
-25,22ย ีดีฌีถ
Income tax expense
-466,23ย ีฐีฆึ€
-466,23ย ีฐีฆึ€
-100,48ย ีฐีฆึ€
-100,48ย ีฐีฆึ€
Effective tax rate
0,60%
0,60%
0,40%
0,40%
Other operating expenses
4,00ย ีดีฌีถ
4,00ย ีดีฌีถ
5,69ย ีดีฌีถ
5,69ย ีดีฌีถ
Net income
-77,07ย ีดีฌีถ
-77,07ย ีดีฌีถ
-25,15ย ีดีฌีถ
-25,15ย ีดีฌีถ
Net profit margin
-5ย 404,23%
-5ย 404,23%
-1ย 194,85%
-1ย 194,85%
Earnings per share
-
-
-
-
Interest and investment income
91,67ย ีฐีฆึ€
91,67ย ีฐีฆึ€
2,15ย ีดีฌีถ
2,15ย ีดีฌีถ
Interest expense
-69,49ย ีดีฌีถ
-69,49ย ีดีฌีถ
-14,18ย ีดีฌีถ
-14,18ย ีดีฌีถ
Net interest expenses
-69,40ย ีดีฌีถ
-69,40ย ีดีฌีถ
-12,03ย ีดีฌีถ
-12,03ย ีดีฌีถ
Depreciation and amortization charges
1,37ย ีดีฌีถ
1,37ย ีดีฌีถ
1,36ย ีดีฌีถ
1,36ย ีดีฌีถ
EBITDA
-12,66ย ีดีฌีถ
-12,66ย ีดีฌีถ
-15,35ย ีดีฌีถ
-15,35ย ีดีฌีถ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google Apps